Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Spectrum Pharma: Trends Indicate Investors Are Paying Attention

|Includes: Spectrum Pharmaceuticals, Inc. (SPPI)
Since I began writing back on June 12, I have paid close attention and tracked the popularity trends of my articles. When I post a new article, it usually rises to the top of the most popular list. Afterwards, the older articles I cite in the newer article tend to follow.

Just to give you an idea about the kind of exposure my articles generate: the first article I published on June 12, 2009 generated between 4,000 and 5,000 unique visits at BMR in a period of three days.

With that in mind, the exposure received at SeekingAlpha should be significantly higher.

Do not misinterpret my intent as I am not interested in patting myself on the back. Rather, I point this out to illustrate that investors are taking notice of Spectrum Pharmaceuticals (NASDAQ:SPPI). I remain confident that, other institutional investors and hedge funds will catch on sooner than later.

Most Popular: Top Five Articles
Nov 22, 2009
Spectrum Pharma: Zevalin Sales Ramp Up
Oct 25, 2009
Spectrum Pharma: Zevalin Has Blockbuster Potential
Sep 20, 2009
Spectrum Pharma: Despite Share Offering, Still Cheap vs. Other Cancer Drug Makers
Nov 03, 2009
Spectrum Pharma: CMS Rules in Favor of Zevalin
Jun 12, 2009
Two Possible Upcoming Approvals for Spectrum Pharmaceuticals

Disclosure: Long SPPI.